Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 6;21(1):58.
doi: 10.1186/s12889-020-10145-1.

Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo

Affiliations

Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo

Arnold J Sadio et al. BMC Public Health. .

Abstract

Background: To date, there is no effective treatment for COVID-19, which is a pandemic disease, caused by a novel coronavirus called SARS-CoV-2. In Togo, where four in five people practice self-medication, the absence of a cure for COVID-19 and the constant progression of the disease requires an assessment of self-medication patterns in the context of the pandemic. This study aimed to estimate the prevalence of self-medication to prevent COVID-19 and its associated factors in Lomé, Togo.

Methods: A cross-sectional study was conducted in Lomé, the capital city of Togo, from April 23rd to May 8th, 2020, with a sample of participants from five sectors: the healthcare, air transport, police, road transport and informal sectors. The participants were invited to provide information about their self-medication practices to prevent COVID-19 in the 2 weeks preceding the survey.

Results: A total of 955 participants (71.6% men) with a median age of 36 (IQR 32-43) were included. Approximately 22.1% were in the air transport sector, 20.5% were in the police sector, and 38.7% were in the health sector. The overall prevalence of self-medication to prevent COVID-19 was 34.2% (95% CI: 31.2-37.3%). The most commonly used products were vitamin C (27.6%) and traditional medicine (10.2%). Only 2.0% of participants reported using chloroquine/hydroxychloroquine. Female sex (aOR=1.90; p< 0.001), work in the health sector (aOR=1.89; p= 0.001), secondary education level (aOR= 2.28; p= 0.043) and university education level (aOR= 5.11; p< 0.001) were associated with self-medication.

Conclusion: One-third of the individuals in high-risk populations in Lomé practiced self-medication. Intensifying awareness campaigns is crucial to fight misinformation about alleged COVID-19 prevention products on social media.

Keywords: COVID-19; Lomé-Togo; Prevention; SARS-CoV-2; Self-medication; Traditional medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
shows factors associated with self-medication to prevent the infection to SARS-CoV-2 in high-risk populations, Lomé, Togo in a binary logistic multivariable model. These associations were expressed as adjusted odds ratios. Self-medication was coded as a binary variable (=1 if intake of at least one product and = 0 if not)

Similar articles

Cited by

References

    1. Al-Mandhari A, Samhouri D, Abubakar A, Brennan R. Coronavirus Disease 2019: preparedness and readiness of countries in the Eastern Medi-terranean Region. East Mediterr Health J. 2020;26(2):136–137. doi: 10.26719/2020.26.2.136. - DOI - PubMed
    1. World Health Organization (WHO) Coronavirus disease (COVID-19) Situation Report–193. Geneva: WHO; 2020. p. 17p.
    1. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends. 2020. 10.5582/bst.2020.01047. - PubMed
    1. Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S. al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020:101738. 10.1016/j.tmaid.2020.101738. - PMC - PubMed
    1. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M. al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949. 10.1016/j.ijantimicag.2020.105949. - PMC - PubMed